An Unusual Case of Flecainide-induced QT Prolongation Leading to Cardiac Arrest-Reference-Cited by-同舟云学术

An Unusual Case of Flecainide-induced QT Prolongation Leading to Cardiac Arrest

Published:2014-02-07 Issue:5 Volume:34 Page:e30-e33
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Oguayo Kevin N.¹²,Oyetayo Ola O.³⁴,Costa Steven M.²⁵,Mixon Timothy A.²⁵

Affiliation:

1. Department of Internal Medicine; Baylor Scott & White Healthcare; Temple Texas

2. College of Medicine; Texas A&M University Health Science Center; Temple Texas

3. Pharmacy Department; Baylor Scott & White Healthcare; Temple Texas

4. College of Pharmacy; Texas A&M University Health Science Center; Temple Texas

5. Division of Cardiology; Baylor Scott & White Healthcare; Temple Texas

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1403/fullpdf

Reference19 articles.

1. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society;Fuster;Circulation,2006

2. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation;Lafuente-Lafuente;Cochrane Database Syst Rev,2012

3. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association;Camm;Eur Heart J,2012

4. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Europace,2010

5. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial;Echt;N Engl J Med,1991

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Interactions Affecting Antiarrhythmic Drug Use;Circulation: Arrhythmia and Electrophysiology;2022-05

2. COVID-19 infection and cardiac arrhythmias;Trends in Cardiovascular Medicine;2020-11

3. Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019;Journal of the American Heart Association;2020-07-21

4. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs;Journal of Pharmacological and Toxicological Methods;2017-09

5. Role of abnormal repolarization in the mechanism of cardiac arrhythmia;Acta Physiologica;2017-07